19 results
Search Results
2. Impacto del COVID-19 en la esperanza de vida en los municipios de los estados del noreste de México.
- Author
-
Javier Uribe-Salas, Felipe, Núñez-Medina, Gerardo, and Parra-Ávila, Juan
- Subjects
LIFE expectancy ,CITIES & towns ,MORTALITY - Abstract
Copyright of Revista CienciaUAT is the property of Universidad Autonoma de Tamaulipas and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
3. COVID-19 en receptores de trasplante: reporte multicéntrico de la experiencia mexicana.
- Author
-
Sánchez-Cárdenas, Mónica, Vásquez-Jiménez, Enzo, Velázquez-Silva, Ricardo I., Vilatobá-Chapa, Mario, Gómez-Navarro, Benjamín, Sánchez-Macías, Lucio O., Rodríguez-Chagolla, José M., García-Juárez, Ignacio, Abraham-Mancilla, Severo M., Morales-Buenrostro, Luis E., Parra-Ávila, Idalia, and Flores-Gama, César
- Abstract
Background: Solid Organ Transplant recipients (SOTR) appear to be at particular high risk for critical COVID-19 due to immunosuppressive drugs and comorbidities. We report the first description of clinical course and short-term outcomes of kidney and liver transplant recipients with confirmed COVID-19 in Mexico. Objective: The objective of this paper was evaluate the clinical course of transplant patients with COVID-19 infection. Methods: We retrospectively evaluated SOTR (kidney and liver) over 18 years of age with confirmed diagnosis of COVID-19 from tertiary care centers in Mexico. Results: Data from 45 kidney transplant recipients were recorded. Median (IQR) age was 43 (IQR 25-70) years. Admission to hospital was required in 37 (75.5 %) patients, of which 8 (16.3%) were hospitalized at Intensive Care Unit (ICU). Acute kidney injury (AKI) stage was documented in 33 (67%) patients. The time of hospitalization was 8 (IQR 6-12) days. Six patients died (12.2%). Additionally, data from 10 liver transplant recipients were included. During their evolution, 5 / 10 required hospital admission and there were no deaths in this group. Conclusions: Transplant recipients show a higher fatality rate and complications from SARS-CoV-2 infection; more studies are needed to identify prognostic factors and effective anti-SARS-CoV-2 therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. LA EFICIENCIA TÉCNICA DE LOS SISTEMAS DE SALUD: UNA RESPUESTA A LA MORTALIDAD POR LA PANDEMIA.
- Author
-
Suin-Guaraca, Luis
- Subjects
- *
MORTALITY , *COVID-19 pandemic , *PUBLIC spending , *MEDICAL care , *PUBLIC health , *DISEASE incidence - Abstract
The Covid-19 pandemic caused an unusual population mortality rate. This paper aims to determine a causal relationship and its incidence between the Technical Efficiency (TE) of health systems and the Covid-19 mortality rate. Using the Data Envelopment Analysis (DEA) methodology and the OLS, GLS and 2SLS adjustment methods, in 108 countries grouped according to per capita health expenditure, it was found that a 1% increase in the TE of the health systems of the analyzed countries reduces the number of deaths from Covid-19 by between 61 and 127 per hundred thousand inhabitants, concluding that the efficiency of expenditure was transcendental in the prevention of mortality caused by the pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Methodological elements for the comparative analysis of the first wave of the Covid-19 epidemic in France, Italy, and Spain.
- Author
-
Aldea-Ramos, Néstor
- Subjects
COVID-19 pandemic ,COVID-19 ,WAVE analysis ,COMPARATIVE studies ,MIDDLE East respiratory syndrome ,SARS-CoV-2 ,EPIDEMICS - Abstract
Copyright of Investigaciones Geograficas is the property of Universidad de Alicante, Instituto Universitario de Geografia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
- Full Text
- View/download PDF
6. ¿ECONOMÍA O SALUD? UN ANÁLISIS GLOBAL DE LA PANDEMIA DE COVID-19.
- Author
-
Chicaíza Becerra, Liliana, García Molina, Mario, and Leonardo Urrea, Iván
- Subjects
COVID-19 pandemic ,ECONOMIC expansion ,MORTALITY ,INTERNATIONAL trade ,HEALTH management ,EMPLOYMENT ,GROSS domestic product ,CRISIS management - Abstract
Copyright of Revista de Economía Institucional is the property of Universidad Externado de Colombia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
7. Enfermedades crónicas degenerativas como factor de riesgo de letalidad por COVID-19 en México.
- Author
-
Ángeles Correa, María Guadalupe, Villarreal Ríos, Enrique, Galicia Rodríguez, Liliana, Vargas Daza, Emma Rosa, Frontana Vázquez, Gabriel, Monrroy Amaro, Sergio Javier, Ruiz Pinal, Viridiana, Dávalos Álvarez, Javier, and Santibáñez Beltrán, Shaid
- Subjects
- *
TYPE 2 diabetes , *COVID-19 , *CHRONIC kidney failure , *ELECTRONIC health records , *CHRONIC diseases - Abstract
Objective. To determine the relative risk of a lethal outcome associated with chronic degenerative conditions in patients with COVID-19. Methods. A cohort study was conducted using electronic medical records belonging to patients who tested positive for COVID-19 on RT-PCR while receiving care as outpatients or inpatients in a social security system facility between March 2020 and March 2021. Two study groups were formed. The exposed group was divided into four subgroups, each of which was diagnosed with one and only one chronic condition (diabetes, hypertension, obesity, or chronic kidney disease); the unexposed group was obtained from the medical records of patients without comorbidities. A total of 1 114 medical records were examined using simple random sampling. Once the minimum sample size was reached, the relative risk was calculated for each chronic condition. Combinations of two, three, and four conditions were created, and each of them was included in the analysis. Results. In the absence of a chronic degenerative condition, the prevalence of a lethal outcome from COVID-19 is 3.8%; in the presence of type 2 diabetes mellitus, 15.8%; in the presence of arterial hypertension, 15.6%; and in the presence of obesity, 15.0%. For diabetes and hypertension combined, the prevalence of a lethal outcome is 54.1%; for diabetes and obesity combined, 36.8%, and for obesity and hypertension combined, 28.1%. Conclusion. In patients with COVID-19, the relative risk of a lethal outcome is 4.17 for those with diabetes, 4.13 for those with hypertension, and 3.96 for those with obesity. For two chronic conditions combined, the relative risk doubles or triples. The relative risk of a lethal outcome is 14.27 for diabetes plus hypertension; 9.73 for diabetes plus obesity, and 7.43 for obesity plus hypertension. Chronic conditions do not present alone; they generally occur together, hence the significance of the relative risks for lethal outcomes presented in this paper. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Estimating national excess mortality from subnational data: application to Argentina.
- Author
-
Karlinsky, Ariel
- Subjects
- *
COVID-19 , *MORTALITY - Abstract
This paper presents a method to estimate excess mortality where national data are missing for some or all of the coronavirus disease 2019 (COVID-19) pandemic period, but subnational data exist, such as in Argentina. By making use of the stability of the regional distribution of deaths, data on deaths in Córdoba province were used to project excess deaths in Argentina from March 2020 up to the end of 2021. The number of excess deaths was estimated at 134 504, which is 14.8% higher than the reported number of COVID-19 deaths in Argentina for the same time period. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Prognostic capacity of D-dimer in predicting mortality in patients diagnosed with COVID-19.
- Author
-
Alburqueque-Melgarejo, Joseph, Guerra Cuyutupac, Israel Armando, Carlos Ezequiel Roque-Quezada, Juan, Virú Flores, Horus Michael, Aguirre Coronado, Martha Eugenia, and Nieves Cordova, Luis Enrique
- Subjects
RECEIVER operating characteristic curves ,MYOCARDIAL ischemia ,FISHER exact test ,FIBRIN fibrinogen degradation products ,RETROSPECTIVE studies ,REVERSE transcriptase polymerase chain reaction ,CHI-squared test ,MANN Whitney U Test ,DESCRIPTIVE statistics ,THROMBOCYTOPENIA ,INTENSIVE care units ,ATRIAL fibrillation ,OBSTRUCTIVE lung diseases ,SOCIODEMOGRAPHIC factors ,DATA analysis software ,CEREBROVASCULAR disease ,COVID-19 ,BIOMARKERS ,COMORBIDITY ,SENSITIVITY & specificity (Statistics) ,DIABETES - Abstract
Copyright of Revista de la Facultad de Medicina Humana is the property of Instituto de Investigaciones en Ciencias Biomedicas de la Universidad Ricardo Palma and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
10. Daño cardiovascular en la COVID-19: Una extensión de la enfermedad pulmonar.
- Author
-
Ochoa Montes, Luis A. and Ferrer Marrero, Daisy
- Abstract
Faced with a pneumonia outbreak in 59 suspected patients at a local seafood market in Wuhan, China, the first case of a novel coronavirus was laboratory-confirmed on December 1, 2019. On January 7, 2020, a new type of virus of the family Coronaviridae called SARS-CoV-2 –causative agent of COVID-19– was identified. The few initial reports restricted involvement to the lower respiratory tract. Both, disease progression and build-up of scientific evidence, proved the crucial role played by cardiovascular involvement in the development and prognosis of the infection. Age is an independent predictor of mortality and an association between pre-existing cardiovascular disease and severe forms of the disease has been demonstrated. Cardiovascular involvement may be either direct or indirect; acute myocardial injury, myocarditis, acute myocardial infarction, heart failure, arrhythmias and venous embolic events stand out among others. Adverse effects of treatment for cardiac complications and drug testing in therapeutic protocols may be contributing aspects. This paper addresses cardiovascular involvement due to COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2021
11. CLINICAL-EPIDEMIOLOGICAL AND TREATMENT CHARACTERISTICS OF CHILDREN WITH COVID-19 IN A TERTIARY REFERRAL CENTER IN PERÚ.
- Author
-
Chiara Chilet, Christian, Luna Vilchez, Medalit, Maquera-Afaray, Julio, Salazar Mesones, Blanca, Portillo Alvarez, Diana, Priale Miranda, Ramiro, Mendoza, Franklin, Munayco, Aldo, Santiago, Mitsi, and López, Jose W.
- Subjects
MORTALITY risk factors ,ANTIBIOTICS ,RESPIRATORY diseases ,COVID-19 ,FEVER ,TERTIARY care ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,CRITICAL care medicine ,COMORBIDITY ,CHILDREN - Abstract
Copyright of Revista de la Facultad de Medicina Humana is the property of Instituto de Investigaciones en Ciencias Biomedicas de la Universidad Ricardo Palma and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
- Full Text
- View/download PDF
12. Risk factors associated with COVID-19 infection and mortality in nursing homes
- Author
-
Idoia Beobide Telleria, Alexander Ferro Uriguen, Esther Laso Lucas, Cinzia Sannino Menicucci, Maria Enriquez Barroso, and Adolfo López de Munain Arregui
- Subjects
COVID-19 ,Persona mayor frágil ,Infecciones ,Mortalidad ,Centros residenciales ,Medicine (General) ,R5-920 - Abstract
Objective: The aim of this paper was to analyse the association of demographic, clinical and pharmacological risk factors with the presence of SARS-COV-2 virus infection, as well as to know the variables related to mortality from COVID-19 in nursing home (NH) residents. Design: Retrospective case–control study. The study variables of those residents who acquired the infection (case) were compared with those of the residents who did not acquire it (control). A subgroup analysis was carried out to study those variables related to mortality. Site: Nursing homes in the region of Guipúzcoa (Spain). Participants and interventions: 4 NHs with outbreaks of SARS-CoV-2 between March and December 2020 participated in the study. The infectivity and, secondary, mortality was studied, as well as demographic, clinical and pharmacological variables associated with them. Data were collected from the computerised clinical records. Main measurements: Infection and mortality rate. Risk factors associated with infection and mortality. Results: 436 residents were studied (median age 87 years (IQR 11)), 173 acquired SARS-CoV-2 (39.7%). People with dementia and Global Deterioration Scale ≥6 were less likely to be infected by SARS-CoV-2 virus [OR = 0.65 (95% CI 0.43–0.97; p
- Published
- 2022
- Full Text
- View/download PDF
13. Un acercamiento a la muerte por COVID-19 en Cuba.
- Author
-
González, Rafael Araujo
- Subjects
AGE groups ,CAUSES of death ,COVID-19 ,MORTALITY ,PUBLIC health - Abstract
Copyright of Revista Novedades en Población is the property of Universidad de La Habana, Centro de Estudios Demograficos and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
14. La mortalidad del COVID-19 como prueba factual para fortalecer las estrategias de seguridad y defensa.
- Author
-
Núñez Cuevas, Juan Camilo
- Subjects
COVID-19 pandemic ,INTERNATIONAL organization ,DEPENDENT variables ,PANDEMICS ,SOCIAL change ,TERRORISM - Abstract
Copyright of Revista Científica General José María Córdova is the property of Escuela Militar de Cadetes General Jose Maria Cordova and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
15. Análisis espacial de riesgo de morbilidad y mortalidad por COVID-19 en Europa y el Mediterráneo en el año 2020
- Author
-
Hilda C. Grassi, Juan Ygnacio López-Hernández, Ledyz Cuesta-Herrera, Jesús E. Andrades-Grassi, Hugo Torres-Mantilla, Guillermo Bianchi-Pérez, and Gaia
- Subjects
Mediterranean climate ,Coronavirus disease 2019 (COVID-19) ,Geography, Planning and Development ,Disease clusters ,COVID-19 ,Mediterranean ,Morbilidad ,Clústers de enfermedades ,Europe ,Geography ,Disease spatial risk ,Homogeneous ,Mortality data ,Riesgo espacial para enfermedades ,Mortalidad ,Pandemic ,Morbidity ,Mortality ,Europa ,Mediterráneo ,Earth-Surface Processes ,Demography - Abstract
Digital, Disease mapping seeks to represent the risk of a disease. This paper focuses on the spatial analysis of risk for pandemic COVID-19 in Europe and the Mediterranean. Morbidity and mortality data for 54 countries in ratio format were used. Two hypotheses were considered, the first one is that the data are homogeneous and the second one is that the ratios are defined in a heterogeneous manner requiring the stratification on the basis of covariables and the methodology of Jenks’ intervals. Spatial risk models were applied as well as methods for the representation of clusters. The results show that the best representation is obtained with the Poisson-Gamma Model under stratification. The variations in the ratios are due to the individual policies of each country for the management of the pandemic. The cluster analysis shows that there is a high mortality process in Eastern Europe. The behavior of the pandemic should be evaluated in the space-time process as well as in other heterogeneous and highly unequal regions., El mapeo de enfermedades busca representar el riesgo de una enfermedad. El objetivo de este trabajo es hacer un análisis del riesgo para la pandemia de COVID-19 en Europa y el Mediterráneo. Se utilizaron los datos de morbilidad y mortalidad en formato de tasas de 54 países. Se aplicaron dos hipótesis, la primera es que los datos son homogéneos y la segunda es que las tasas son definidas de forma heterogénea por lo que se estratificó en base a covariables y la metodología de los intervalos de Jenks. Se aplicaron modelos espaciales de riesgos así como métodos de representación de clústers. Los resultados muestran que el modelo Poisson-Gamma bajo estratificación es el que mejor representa el proceso. Las variaciones de las tasas se deben a la heterogeneidad en las políticas individuales de cada país para el manejo de la pandemia. Los análisis clusters muestran que existe un fuerte proceso de mortalidad ubicado en Europa del Este. Debe evaluarse el comportamiento del proceso de la pandemia en el espacio-tiempo así como en otras regiones heterogéneas y altamente desiguales., Ingeniería Ambiental, Investigación Aplicada
- Published
- 2020
16. Evaluación de escalas de riesgo en pacientes con neumonía Covid-19
- Author
-
Bedia Echevarría, Blanca, Alonso Valle, Héctor, and Universidad de Cantabria
- Subjects
FINE ,Mortalidad ,Risk models ,COVID-19 ,Escalas de riesgo ,Mortality - Abstract
RESUMEN : Introducción: La pandemia causada el COVID-19 ha supuesto una importante carga asistencial en los centros sanitarios de todo el mundo. Debido al enorme volumen de pacientes con necesidad de atención medica hospitalaria, se han utilizado diferentes escalas de predicción de riesgo con el fin de identificar cuáles son aquellos pacientes que tienen mayor riesgo de mala evolución y de mortalidad, y de esta manera ofrecer la mejor atención sanitaria. Objetivos: El objetivo de este trabajo es comparar la utilidad pronostica de cuatro escalas de gravedad, FINE, CURB-65, PREDICOVID y CALL Score. Así como conocer la incidencia del COVID-19 en el Hospital Universitario Marqués de Valdecilla entre el 1 de Marzo de 2020 y el 30 de abril de 2020. Método: Estudio analítico, descriptivo y retrospectivo de 313 pacientes diagnosticados de COVID-19. Se recogieron como variables la edad, el sexo, el diagnostico de neumonía bilateral, la necesidad de ingreso en UCI, la mortalidad intrahospitalaria, los niveles de dímero D, así como las variables para las diferentes escalas. Resultados: La mortalidad intrahospitalaria fue del 23,5% y la tasa de ingreso en UCI del 8,9%. La escala PSI/FINE es la que mejor AUC mostro con un valor de 0,764 (IC 95% 0,683-0,845). Conclusión: Este estudio evidencia que la escala PSI/FINE es la que mejor capacidad predictiva de mortalidad intrahospitalaria. Ninguna de ellas es capaz de determinar con precisión la necesidad de ingreso en UCI. ABSTRACT : Introduction: The COVID-19 pandemic has made an important assistance charge in different hospitals around the world. Due to the large number of patients who needed medical attention in hospitals, different risk models had been used to identify which patients would get higher risk of bad performance and dead, so we could offer a better medical assistance. Objectives: The aim of this paper is to evaluate the helpfulness of four risk models, PSI, CURB-65, PREDICOVID and CALL Score. We have assessed the impact of COVID-19 in Hospital Universitario Marques de Valdecilla between March 1st 2020 and April 30th 2020 as well. Method: Analytic descriptive and retrospective study of 313 patients with COVID 19 pneumonia. We recorded age, sex, bilateral pneumonia diagnosis, ICU admission, in-hospital mortality, D dimer levels and risk models variables. Results: In hospital mortality was 23,5% and ICU admission 8,9%. PSI showed an ACU of 0,764 (IC 95% 0,683-0,845). Conclusions: This study shows that PSI has the best accuracy predicting in hospital mortality risk. None of them could determine acceptably the requirement of admission in ICU. Grado en Medicina
- Published
- 2022
17. Methodological elements for the comparative analysis of the first wave of the Covid-19 epidemic in France, Italy, and Spain
- Author
-
Aldea-Ramos, Néstor
- Subjects
Epidemiology ,Health ,Mortalidad ,COVID-19 ,Epidemiología ,Demografía ,Salud ,Mortality ,Demography - Abstract
The three European countries included in the northwest littoral of the Mediterranean region – Italy, France and Spain – reported their first cases of the SARS-CoV-2 coronavirus early in 2020. The subsequent epidemic strongly impacted these countries, challenging the healthcare systems efficiency, and the capacity and transparency of their public statistics structures. Because public statistics were not fully adapted to such a new health situation, the available official data could not wholly describe the epidemic correctly. This paper developed an indicator derived from the prevalence of SARS-CoV-2 aiming to describe the time and spatial dynamics of the epidemic. Although the analysis was not applied to France due to the lack of data available, the comparative analysis among Spain and Italy highlighted some similarities and certain divergences, partially attributable to the features of each country‘s national demographic patterns and the peculiarities of applied health protocols. Finally, mortality during the first wave of the epidemic has been analysed for the three countries, demonstrating higher mortality index in Spain, although the reported number of SARS-CoV-2 declared deaths does not explain a portion of this mortality excess. Los tres países europeos que conforman el litoral noroeste del Mediterráneo —Italia, Francia y España— notificaron sus primeros casos del nuevo coronavirus SARS-CoV-2 al comienzo del año 2020. La consiguiente epidemia impactó intensamente estos países, desafiando la eficiencia de sus sistemas de atención sanitaria, así como la capacidad y transparencia de sus estructuras de estadística pública. Dado que la estadística pública no estaba completamente adaptada a la nueva situación sanitaria, los datos oficiales disponibles no pudieron describir en su totalidad la epidemia de manera correcta. Esta contribución ha desarrollado un indicador derivado de la prevalencia del SARS-CoV-2 con el objetivo de analizar la dinámica espacio-temporal de la epidemia. Aunque el análisis no se ha aplicado en Francia debido a la falta de datos, el análisis comparativo entre España e Italia destaca ciertas similitudes y algunas diferencias, parcialmente atribuibles a las características demográficas propias de cada país, así como a los protocolos sanitarios puestos en marcha. Por último, la mortalidad durante la primera ola de la epidemia en los tres países ha sido analizada, mostrando una mayor tasa de mortalidad en España, si bien parte de ese exceso de mortalidad no se explica por el número de defunciones declaradas por causa de SARS-CoV-2.
- Published
- 2021
18. Impacto de la pandemia de COVID-19 en América Latina y el Caribe: La mortalidad en Perú, con especial referencia al exceso de mortalidad
- Author
-
Paz, Jorge Augusto, Binstock, Georgina, Nathan, Mathias, Pardo, Ignacio, and Pelaez, Enrique
- Subjects
Perú ,purl.org/becyt/ford/5 [https] ,Mortalidad ,COVID-19 ,purl.org/becyt/ford/5.4 [https] ,Exceso de mortalidad - Abstract
En este trabajo se muestra la evolución del exceso de mortalidad en Perú durante 2020. El exceso de mortalidad es la diferencia entre las defunciones observadas y las que se espera que hubiesen ocurrido de no enfrentar una pandemia como la del nuevo coronavirus. Combinando información de diversas fuentes, se encontró que, durante un período de 45 semanas de 2020, murieron más del doble de personas de lo esperado, según el número de muertes registradas en promedio durante el mismo período de tiempo en los 3 años anteriores (2017-2019). El exceso de mortalidad es mayor entre los hombres, y, particularmente elevado entre los 35 y los 64 años, grupo en el que se encuentra la mayor proporción de la población económicamente activa y ocupada. El documento advierte acerca de algunas de sus limitaciones, y destaca la gran utilidad de contar con información actualizada y desagregada sobre defunciones, como las que proporciona Perú. This paper shows the evolution of excess mortality in Peru during 2020. Excess mortality is the difference between the deaths observed and those expected to have occurred, had they not faced a pandemic such as the new coronavirus. Combining information from various sources, it was found that, during a 45- week period in 2020, more than twice as many people died than expected based on the number of deaths recorded on average during the same time period in the previous 3 years (2017- 2019). Excess mortality is higher among men and particularly high between 35 and 64 years of age, a group in which the highest proportion of the economically active and employed population is found. The document warns about some of its limitations, and highlights the great utility of having updated and disaggregated information on deaths, such as those provided by Peru. Fil: Paz, Jorge Augusto. Universidad Nacional de Salta. Facultad de Ciencias Económicas, Jurídicas y Sociales. Instituto de Estudios Laborales y del Desarrollo Económico; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta; Argentina
- Published
- 2021
19. Economia ou saúde? Uma análise global da pandemia COVID-19
- Author
-
Chicaíza Becerra, Liliana, García Molin, Mario, and Urrea, Iván Leonardo
- Subjects
mortalidade ,pandemic ,international trade ,pandemia ,COVID-19, pandemia, crecimiento económico, mortalidad, comercio exterior ,COVID-19, pandemia, crescimento econômico, mortalidade, comércio exterior ,COVID-19 ,crecimiento económico ,economic growth ,mortality ,COVID-19, pandemic, economic growth, mortality, international trade ,H50, H53, F18 ,crescimento econômico ,comércio exterior ,mortalidad ,jel:H50, H53, F18 ,comercio exterior - Abstract
Resumen Este artículo estudia la relación entre el manejo sanitario de la pandemia de COVID-19 y los resultados económicos. Identifica algunos indicadores de mortalidad y económicos que toman en cuenta elementos sociales y culturales. Examina el efecto de los precios del petróleo en la capacidad de maniobra de los países exportadores, y el modo en que la disrupción del comercio exterior afectó a las cadenas globales de valor. Los países con mejores resultados en salud durante la pandemia mostraron menores caídas del PIB en el segundo trimestre de 2020. El mejor predictor de buenos resultados económicos fue la solidez del sistema de salud en número de camas antes de la pandemia. Abstract This paper identifies the relationship between the health management of the COVID-19 pandemic and the economic outcomes. It shows economic and mortality indicators as well as other social and cultural variables affecting the results. It takes into account the effect of oil prices upon the exporting countries leeway. It also shows how the disruption in international trade affected global value chains. Countries with better health results during the pandemic showed better results in economic growth in the second quarter of 2020. The best predictor of economic success was the health system strengh measured by number of beds prior to the pandemic. Resumo Este artigo estuda a relação entre a gestão em saúde da pandemia COVID-19 e os resultados econômicos. Identifique alguns indicadores de mortalidade e econômicos que levem em consideração elementos sociais e culturais. Ele examina o efeito dos preços do petróleo na capacidade de manobra dos países exportadores e como a interrupção do comércio exterior afetou as cadeias de valor globais. Os países com os melhores resultados de saúde durante a pandemia mostraram quedas mais baixas do PIB no segundo trimestre de 2020. O melhor indicador de bom desempenho econômico foi a força do sistema de saúde em número de leitos antes da pandemia.
- Published
- 2020
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.